Achilles’ US IPO closed with proceeds of $175m
The Cancer Research UK spinout is developing precision T cell therapies to treat multiple cancers
Read More
Tag: UCL Business
Cell Medica links with UCL in research deal
Cell Medica has signed a research deal with University College London for access to its novel T cell receptor technology, in a bid to generate leading-edge modified TCR products for the treatment of cancer.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
